Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [21] The effect of activated clotting time values for patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis
    Gui, Yi-Yue
    Huang, Fang-Yang
    Huang, Bao-Tao
    Peng, Yong
    Liu, Wei
    Zhang, Chen
    Chen, Shi-Jian
    Pu, Xiao-Bo
    Wang, Peng-Ju
    Chen, Mao
    THROMBOSIS RESEARCH, 2016, 144 : 202 - 209
  • [22] The Future of Activated Clotting Time? Response
    Shore-Lesserson, Linda
    Ferraris, Victor
    Fitzgerald, David
    Baker, Robert A.
    ANESTHESIA AND ANALGESIA, 2018, 127 (02): : E26 - E27
  • [23] WHAT IS THE RIGHT ACTIVATED CLOTTING TIME
    WEINER, BH
    VOYCE, S
    HELLER, LI
    LAIFER, LI
    CIRCULATION, 1992, 86 (04) : 250 - 250
  • [24] Is the activated clotting time dangerous? Reply
    Avidan, MS
    Despotis, GJ
    ANESTHESIOLOGY, 2005, 103 (04) : 904 - 904
  • [25] EFFECT OF APROTININ ON ACTIVATED CLOTTING TIME, WHOLE-BLOOD AND PLASMA HEPARIN MEASUREMENTS
    DESPOTIS, GJ
    JOIST, JH
    JOINERMAIER, D
    ALSOUFIEV, AL
    TRIANTAFILLOU, AN
    GOODNOUGH, LT
    SANTORO, SA
    LAPPAS, DG
    ANNALS OF THORACIC SURGERY, 1995, 59 (01): : 106 - 111
  • [26] VARIABILITIES IN MEASUREMENTS OF POINT OF CARE ACTIVATED CLOTTING TIME (ACT) IN THE INTERVENTIONAL CARDIOLOGY PROCEDURES
    Saadat, Vandad
    Amini, Mohammad Reza
    Fearon, Colleen
    Fraser, Gary E.
    Abudayyeh, Islam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 911 - 911
  • [27] Minimum discard volume to obtain reliable activated clotting time from the heparinized arterial line
    Erden, Ismail Aydin
    Ayhan, Banu
    Oz, Goksen
    Kanbak, Meral
    Celebioglu, Bilge
    Aypar, Ulku
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 20 (04): : 794 - 798
  • [28] In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients
    Tanaka, Kenichi A.
    Henderson, Reney
    Thangaraju, Kiruphagaran
    Morita, Yoshihisa
    Mazzeffi, Michael A.
    Strauss, Erik
    Katneni, Upendra
    Buehler, Paul W.
    HAEMOPHILIA, 2022, 28 (01) : 183 - 190
  • [29] Systematic review of emergency department central venous and arterial catheter infection
    LeMaster C.H.
    Agrawal A.T.
    Hou P.
    Schuur J.D.
    International Journal of Emergency Medicine, 2010, 3 (4) : 409 - 423
  • [30] EFFECT OF CELITE AND KAOLIN ON ACTIVATED CLOTTING TIME IN THE PRESENCE OF APROTININ - ACTIVATED CLOTTING TIME IS REDUCED BY BINDING OF APROTININ TO KAOLIN
    DIETRICH, W
    JOCHUM, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (01): : 177 - 178